Physician profile
Jacquelyn Engwall
NPI 1225813587
$838.39
in general payments reported to CMS, 2019-2025
16 companies · $365 in 2025
The $365 reported for 2025 was more than what 75% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $47.11 · 2024: $426 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $798 · Education: $40.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $798.34 |
| Education | $40.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $148.77 | 2024-2025 | Zurzuvae |
| Millicent US INC | $128.81 | 2024-2025 | Femring, Intrarosa |
| Ethicon US, LLC | $104.29 | 2024-2025 | Stratafix, Ethicon, Harmonic |
| Astellas Pharma US INC | $74.72 | 2024 | Veozah |
| Exeltis, USA INC. | $62.08 | 2024-2025 | Slynd |
| Hologic Sales and Service, LLC | $52.59 | 2025 | Aptima |
| Coopersurgical, INC. | $41.90 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Mayne Pharma Commercial LLC | $41.25 | 2023-2024 | |
| Organon LLC | $29.44 | 2024 | |
| Daiichi Sankyo INC. | $28.95 | 2024 | Injectafer |
| Amgen INC. | $24.60 | 2024 | Evenity, Prolia |
| Evofem Biosciences, INC. | $21.75 | 2025 | Solosec, Phexx, Phexxi |
| Aspira Women'S Health INC | $21.23 | 2025 | Ova1 |
| Abbvie INC. | $20.47 | 2024 | |
| Merck Sharp & Dohme LLC | $19.69 | 2024 | Gardasil, Gardasil 9 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17.85 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacquelyn Engwall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.